About this trial
the effect of missed hemodialysis sessions on the occurrence of short-term cardiovascular events in patients with end-stage renal disease receiving maintenance hemodialysis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients aged ≥18 years.
Patients diagnosed with end-stage renal disease (ESRD).
Patients receiving maintenance hemodialysis on a regular schedule (three sessions per week).
Patients on maintenance hemodialysis for at least 3 months prior to enrolment.
Disqualifiers
Patients receiving peritoneal dialysis or other forms of renal replacement therapy.
Patients with acute kidney injury requiring temporary dialysis.
Patients with documented acute cardiovascular events within 30 days prior to study enrolment.
Patients who undergo renal transplantation during the study period.
Trial population
Hemodialysis Unit of Internal Medicine Department
Trial design
Cohort
Prospective
Treatments tested in this trial
Electrocardiography (ECG) and Echocardiography (ECHO)
DeviceA standard 12-lead ECG will be performed for all patients within 72 hours after a missed hemodialysis session to detect abnormalities.Transthoracic echocardiography will be performed as a baseline assessment for all enrolled patients using routine institutional protocols. Repeat echocardiographic examination will be performed only if clinically indicated,Echocardiographic parameters assessed will include left ventricular ejection fraction , left ventricular hypertrophy, regional wall motion abnormalities, diastolic function, and right ventricular function
Treatment groups
Trial outcomes
Primary outcomes
Incidence of short-term cardiovascular events (CVE) following missed hemodialysis sessions
Short-term cardiovascular events will be defined as the occurrence of acute coronary syndrome, acute decompensated heart failure, documented arrhythmias, sudden cardiac death, or cerebrovascular events occurring within 72 hours after a missed hemodialysis session.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: